RYNE Biotechnology Inc.
RYNE Biotechnology Inc. is an iPSC dopamine progenitor founded in 2022.
1
Funding Rounds
$5.0m
Money raised
Overview
RYNE Biotechnology Inc. is an iPSC dopamine progenitor founded in 2022.
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company RYNE Biotechnology Inc. has raised a total of $5m in funding over 1 rounds.
Key Insights:
- RYNE Biotechnology Inc. Funding Round, July 2022: $5m
RYNE Biotechnology Inc. Funding Round, July 2022
$5m
Industries
RYNE Biotechnology Inc. is active in the following industries: